HHS Awards $7.69M Clinical Trial Contract to University of Washington for Contraceptive Efficacy Research

Contract Overview

Contract Amount: $7,686,827 ($7.7M)

Contractor: University of Washington

Awarding Agency: Department of Health and Human Services

Start Date: 2015-09-14

End Date: 2026-12-31

Contract Duration: 4,126 days

Daily Burn Rate: $1.9K/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 2

Pricing Type: COST NO FEE

Sector: R&D

Official Description: IGF::OT::IGF CCTN- MALE SITES - CONTRACEPTIVE EFFICACY CLINICAL TRIAL HHSN275201300025I/HHSN27500006

Place of Performance

Location: SEATTLE, KING County, WASHINGTON, 98195

State: Washington Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $7.7 million to UNIVERSITY OF WASHINGTON for work described as: IGF::OT::IGF CCTN- MALE SITES - CONTRACEPTIVE EFFICACY CLINICAL TRIAL HHSN275201300025I/HHSN27500006 Key points: 1. Contract focuses on contraceptive efficacy clinical trials, a critical area for public health. 2. University of Washington, a leading research institution, is the sole awardee. 3. Potential risks include research delays or unexpected cost overruns in a long-term study. 4. Spending falls within the Research and Development sector, specifically life sciences.

Value Assessment

Rating: good

The contract value of $7.69M over 11 years suggests a reasonable allocation for a multi-site clinical trial. Benchmarking is difficult without specific per-unit cost data for trial participants or specific research activities.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

The contract was awarded under full and open competition, indicating a competitive bidding process. This method generally promotes price discovery and ensures fair market value is sought.

Taxpayer Impact: The investment supports critical public health research, aiming to improve reproductive health outcomes, which has long-term societal benefits.

Public Impact

Supports advancement of reproductive health knowledge. Potential for improved contraceptive options and public health guidance. Long-term research may yield significant public health benefits. Contract duration allows for comprehensive data collection and analysis.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Positive Signals

Sector Analysis

This contract falls under the Research and Development sector, specifically NAICS code 541712 (Research and Development in the Physical, Engineering, and Life Sciences). Spending in this area is crucial for scientific advancement and innovation, with typical contract values varying widely based on project scope and duration.

Small Business Impact

The contract was awarded to a large research institution, the University of Washington. There is no indication of small business participation in this specific award, which is common for large-scale, specialized research projects.

Oversight & Accountability

The contract is managed by the National Institutes of Health (NIH), a component of HHS. NIH has established oversight mechanisms for clinical trials, including regular reporting requirements and scientific review panels to ensure progress and accountability.

Related Government Programs

Risk Flags

Tags

research-and-development-in-the-physical, department-of-health-and-human-services, wa, delivery-order, 1m-plus

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $7.7 million to UNIVERSITY OF WASHINGTON. IGF::OT::IGF CCTN- MALE SITES - CONTRACEPTIVE EFFICACY CLINICAL TRIAL HHSN275201300025I/HHSN27500006

Who is the contractor on this award?

The obligated recipient is UNIVERSITY OF WASHINGTON.

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (National Institutes of Health).

What is the total obligated amount?

The obligated amount is $7.7 million.

What is the period of performance?

Start: 2015-09-14. End: 2026-12-31.

What is the primary objective of this clinical trial and how will its success be measured?

The primary objective is to assess the efficacy of contraceptive methods. Success will be measured through rigorous clinical data collection on pregnancy rates and other relevant health outcomes, adhering to established clinical trial protocols and statistical analysis plans.

What are the key risks associated with the long duration of this contract and how are they being mitigated?

The long duration (over 11 years) poses risks such as evolving scientific understanding, participant retention challenges, and potential budget fluctuations. Mitigation strategies likely include adaptive trial designs, robust participant engagement programs, and contingency planning within the awarded budget.

How does this investment align with broader public health goals related to reproductive health?

This investment directly aligns with public health goals by generating crucial data on contraceptive efficacy. This knowledge can inform clinical practice, guide public health policy, improve access to effective family planning services, and ultimately contribute to better reproductive health outcomes for individuals and communities.

Industry Classification

NAICS: Professional, Scientific, and Technical ServicesScientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

Product/Service Code: RESEARCH AND DEVELOPMENTN – Health R&D Services

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY

Offers Received: 2

Pricing Type: COST NO FEE (S)

Evaluated Preference: NONE

Contractor Details

Address: 4333 BROOKLYN AVE NE, SEATTLE, WA, 98195

Business Categories: Category Business, Educational Institution, Government, Higher Education, U.S. Local Government, U.S. National Government, Not Designated a Small Business, Higher Education (Public), Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $7,686,827

Exercised Options: $7,686,827

Current Obligation: $7,686,827

Actual Outlays: $4,055,998

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED

Cost or Pricing Data: NO

Parent Contract

Parent Award PIID: HHSN275201300025I

IDV Type: IDC

Timeline

Start Date: 2015-09-14

Current End Date: 2026-12-31

Potential End Date: 2026-12-31 00:00:00

Last Modified: 2025-12-11

More Contracts from University of Washington

View all University of Washington federal contracts →

Other Department of Health and Human Services Contracts

View all Department of Health and Human Services contracts →

Explore Related Government Spending